World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
20743
World Ranking
18094
National Ranking
9022

Overview

Brent R. Logan is affiliated with the Medical College of Wisconsin in the United States and has contributed extensively to the field of medicine, particularly in hematology. Their research primarily focuses on hematopoietic stem cell transplantation and related topics within immunology and oncology.

Logan has published in a variety of prominent venues, with frequent contributions to:

  • Transplantation and Cellular Therapy
  • Blood
  • Journal of Clinical Oncology
  • UNC Libraries
  • Blood Advances

The scientist's major fields of study include:

  • Hematology
  • Immunology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Genetics

Brent R. Logan's key research topics involve:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Immunodeficiency and Autoimmune Disorders
  • Renal Transplantation Outcomes and Treatments
  • CAR-T cell therapy research
  • Childhood Cancer Survivors' Quality of Life

Among their recent papers are the following notable publications:

  • Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial (2020), published in Blood
  • National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide (2021), published in Journal of Clinical Oncology
  • Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 (2024), published in Journal of Clinical Oncology
  • Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome (2021), published in Journal of Clinical Oncology
  • Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report (2020), published in Blood

Frequently collaborating co-authors include:

  • Bronwen E. Shaw
  • Steven M. Devine
  • Mary M. Horowitz
  • Michael A. Pulsipher
  • Christopher C. Dvorak

Best Publications

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley

  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Bart L. Scott;Marcelo C. Pasquini;Brent R. Logan;Juan Wu

  • Analyzing survival curves at a fixed point in time.

    John P Klein;Brent Logan;Mette Harhoff;Per Kragh Andersen

  • Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

    Chung Che Chang;Sara McClintock;Ronald P. Cleveland;Trent Trzpuc

  • Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study

    Nelli Bejanyan;Daniel J. Weisdorf;Brent R. Logan;Brent R. Logan;Hai Lin Wang

  • Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

    Christopher S. Hourigan;Laura W. Dillon;Gege Gui;Brent R. Logan

  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

    Amrita Krishnan;Marcelo C Pasquini;Brent Logan;Edward A Stadtmauer

  • Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience

    William T. Shearer;Elizabeth Dunn;Luigi D. Notarangelo;Christopher C. Dvorak

  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

    Michael A. Pulsipher;Pintip Chitphakdithai;John P. Miller;Brent R. Logan

  • Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.

    Amin Majid Alousi;Daniel J. Weisdorf;Brent R. Logan;Javier Bolaños-Meade

  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

    Jennifer Heimall;Brent R. Logan;Morton J. Cowan;Luigi D. Notarangelo

  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

    Naynesh R. Kamani;Mark C. Walters;Shelly Carter;Victor Aquino

  • Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

    Javier Bolaños-Meade;Ran Reshef;Raphael Fraser;Mingwei Fei

  • Comparable survival after HLA–well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

    Vikas Gupta;Martin S. Tallman;Wensheng He;Brent R. Logan

  • Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

    Mohamed L. Sorror;Mohamed L. Sorror;Brent R. Logan;Brent R. Logan;Xiaochun Zhu;J. Douglas Rizzo

  • Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

    John E. Levine;Brent R. Logan;Juan Wu;Amin M. Alousi

  • Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

    Corey Cutler;Brent Logan;Ryotaro Nakamura;Laura Johnston

  • Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

    John T. Horan;Brent R. Logan;Manza A. Agovi-Johnson;Hillard M. Lazarus

Frequent Co-Authors

Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Marcelo C. Pasquini
Marcelo C. Pasquini Medical College of Wisconsin
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
John R. Wingard
John R. Wingard University of Florida
Vincent T. Ho
Vincent T. Ho Harvard University
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Richard T. Maziarz
Richard T. Maziarz Oregon Health & Science University
John E. Levine
John E. Levine Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing the right pathway in the medical field can be challenging, especially with the rising demand for flexibility, affordability, and diverse career options. For those interested in advanced clinical roles without pursuing a full medical degree, exploring the cheapest fnp programs online can be an excellent option to become a Family Nurse Practitioner at a lower cost.

Many students are also turning to online nursing school programs. These provide the convenience of remote learning alongside practical training—making it easier for working professionals or those with family commitments to start a nursing career.

Nurses looking for leadership or academic roles may consider earning a doctorate via phd nursing education online programs. These programs help deepen expertise and open doors to research or teaching positions.

For registered nurses seeking advancement, rn to bsn online cost comparisons are crucial. Earning a BSN online can boost earning potential, job prospects, and readiness for graduate study, all while fitting around a busy work schedule.

Best Scientists Citing Brent R. Logan

Trending Scientists

Recently Published Articles